Following Moran’s last ANIK Sell transaction on May 29, 2015, the stock climbed by 2.9%. In addition to Moran, 3 other ANIK executives reported Sell trades in the last month.
The company has a one year high of $45.35 and a one year low of $31.36. ANIK’s market cap is $536M and the company has a P/E ratio of 21.8%. Currently, Anika Therapeutics Inc. has an average volume of 117.9k.
Looking at blogger coverage of ANIK, there is a 100% Bullish tendency on the stock, in relation to a 67% average bullish tendency within the Healthcare sector.
In the last 30 days, insiders have sold $155.7k worth of ANIK shares and purchased $126.1k worth of ANIK shares. Over the last 3 months, the insider sentiment on Anika Therapeutics Inc. has been neutral based on 14 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.
Anika Therapeutics Incdevelops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.The Company through its subsidiary has over 20 products currently commercialized, mainly in Europe.